Free Trial

ZIVO Bioscience (NASDAQ:ZIVO) Stock Passes Above 50-Day Moving Average - Here's Why

ZIVO Bioscience logo with Medical background

Key Points

  • ZIVO Bioscience's stock price has crossed above its fifty day moving average of $14.36, reaching a high of $18.99 during trading.
  • The company has a market cap of $72.48 million and operates in the biotech and agtech sectors, focusing on natural bioactive ingredients derived from proprietary algae cultures.
  • ZIVO Bioscience's P/E ratio stands at -3.89, indicating negative earnings, which is reflected in its beta of -0.06.
  • MarketBeat previews top five stocks to own in October.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report)'s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $14.36 and traded as high as $18.99. ZIVO Bioscience shares last traded at $18.99, with a volume of 290 shares changing hands.

ZIVO Bioscience Stock Performance

The business's 50-day moving average price is $14.58 and its 200 day moving average price is $16.19. The stock has a market capitalization of $66.80 million, a PE ratio of -3.59 and a beta of -0.06.

About ZIVO Bioscience

(Get Free Report)

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

Featured Articles

Should You Invest $1,000 in ZIVO Bioscience Right Now?

Before you consider ZIVO Bioscience, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.

While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.